No Longer Accepting Cases
Diabetes Drug Invokana May Lead To Amputations
If you have suffered a toe, foot, finger, hand, or leg amputation after taking the diabetes drug Invokana (canagliflozin), significant compensation may be available.
FDA Warns of Invokana Increased Amputation Risk: If you have suffered a toe, foot, or leg amputation after taking the diabetes drug Invokana (canagliflozin), significant compensation may be available.
The U.S. Food and Drug Administration has issued a Safety Communication warning that patients treated with Invokana have an increased risk of amputation of their lower extremities including –
- Middle-foot amputations
- Below the knee leg amputations
- Above the knee leg amputations
- Amputations involving both limbs
- Toe amputations
Do not stop taking the medication without speaking with your doctor first, however, you should seek advice from a healthcare professional as soon as possible if you notice the following on your feet or legs –
- Painful or tender areas
- Ulcers or sores
2017 FDA Safety Announcement
If You Are Taking Invokana and Have Suffered a Foot or Leg Amputation Contact Us Now
In May 2017, the FDA issued a Safety Announcement regarding the outcome of two large clinical studies that determined the risk of foot and leg amputations was increased for diabetic patients who are treated with Invokana. Because of this, the government agency is requiring a new Boxed Warning be added to the Invokana label warning patients and their physicians about this risk.
Pain, sores, ulcers and infection of the legs and feet are an indication that you need to be treated by a physician as soon as possible. Be sure to tell your doctor you are taking Invokana or a combination drug containing canagliflozin.
Two Trials Show Increased Risk of Amputation for Diabetic Patients on Canagliflozin
Researchers in the first clinical trial found that over a 12-month period the occurrence of amputation was equal to – 5.9 out of 1,000 patients being treated with Invokana as opposed to 2.8 out of 1,000 for those treated with placebo.
The second clinical study found that over a 12-month period, the occurrence of amputation equaled –
7.5 out of 1,000 patients being treated with Invokana, as opposed to 4.2 of 1,000 patients being treated with placebo.
Two Trials Show Increased Risk of Amputation
Diabetic patients must already be careful of foot and toe injuries because of the nature of the disease. Invokana was supposed to help diabetic patients live better and healthier lives, yet studies have found the medication may increase the risk of toe, foot, and leg amputations for these patients.
We are currently investigating Invokana foot and leg amputation cases in all 50 states, and we urge you to contact us immediately if you have suffered an amputation. We fight for patients who are harmed by the medications that were supposed to help them, and we will fight for you.
If you or someone you love suffered an amputation after being treated with Invokana® (Invokamet®) you may be entitled to significant compensation through an Invokana® lawsuit.
Pulaski Kherkher PLLC
The lawyers at Pulaski Kherkher PLLC are leaders in pursuing justice and getting compensation for those affected by the wrongdoing of pharmaceutical and medical device companies. We have helped thousands of people get financial recourse for the injuries caused by bad drugs and defective medical devices. Call 1-800-BAD-DRUG | 1-800-223-3784 today to speak with our Invokana lawyers and get the compensation you deserve for your Invokana injuries.